Search Results - "Chung, Matthew S H"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation by Wong, Carlos K. H., Lau, Kristy T. K., Chung, Matthew S. H., Au, Ivan C. H., Cheung, Ka Wang, Lau, Eric H. Y., Daoud, Yasmin, Cowling, Benjamin J., Leung, Gabriel M.

    Published in Nature medicine (2024)
    “…To date, there is a lack of randomized trial data examining the use of the antiviral nirmatrelvir/ritonavir in severe acute respiratory syndrome coronavirus 2…”
    Get full text
    Journal Article
  2. 2

    Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone by Wong, Carlos K H, Lau, Kristy T K, Au, Ivan C H, Xiong, Xi, Chung, Matthew S H, Leung, Belle Y C, Lau, Eric H Y, Cowling, Benjamin J

    Published in Frontiers in pharmacology (30-05-2022)
    “…This retrospective cohort study aims to explore head-to-head clinical outcomes and complications associated with tocilizumab or baricitinib initiation among…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Regression of liver fibrosis after HBsAg loss: A prospective matched case-control evaluation using transient elastography and serum enhanced liver fibrosis test by Mak, Lung-Yi, Hui, Rex Wan-Hin, Chung, Matthew S H, Wong, Danny Ka-Ho, Fung, James, Seto, Wai-Kay, Yuen, Man-Fung

    Published in Journal of gastroenterology and hepatology (26-08-2024)
    “…We assessed the effect of hepatitis B surface antigen (HBsAg) seroclearance (HBsAg-loss) on liver fibrosis regression in patients with chronic hepatitis B…”
    Get full text
    Journal Article
  5. 5

    Optimal Timing of Remdesivir Initiation in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Administered With Dexamethasone by Wong, Carlos K H, Lau, Kristy T K, Au, Ivan C H, Xiong, Xi, Chung, Matthew S H, Lau, Eric H Y, Cowling, Benjamin J

    Published in Clinical infectious diseases (24-08-2022)
    “…Abstract Background Evidence is lacking about any additional benefits of introducing remdesivir on top of dexamethasone, and the optimal timing of initiation…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study by Wong, Carlos K. H., Low, Marshall C. H., Kwok, Ashley C. Y., Lui, Angel Y. C., Lau, Kristy T. K., Au, Ivan C. H., Xiong, Xi, Chung, Matthew S. H., Kwan, Mike Y. W., Lau, Eric H. Y., Cowling, Benjamin J.

    Published in Paediatric drugs (01-05-2022)
    “…Objectives There was initially insufficient understanding regarding suitable pharmacological treatment for pediatric Coronavirus Disease 2019 (COVID-19)…”
    Get full text
    Journal Article
  12. 12

    Bariatric surgery, novel glucose-lowering agents, and insulin for type 2 diabetes and obesity: Bayesian network meta-analysis of randomized controlled trials by Wu, Tingting, Wong, Carlos K H, Lui, David T W, Wong, Simon K H, Lam, Cindy L K, Chung, Matthew S H, McAllister, David A, Welbourn, Richard, Dixon, John B

    Published in BJS open (10-07-2023)
    “…Abstract Background This network meta-analysis aimed to compare the effects of bariatric surgery, novel glucose-lowering agents (SGLT2i, GLP1RA, DPP4i), and…”
    Get full text
    Journal Article
  13. 13